Centralisation of complex pathologies in honours of excellence. How to do it? J. Escrig Sos Editorial 21 June 2007 Pages: 267 - 268
Molecular determinants of invasion in endometrial cancer M. AbalM. LlauradóJ. Reventos Educational Series 21 June 2007 Pages: 272 - 277
Hypoxia-inducible factors and cancer M. J. CalzadaL. del Peso Educational Series 21 June 2007 Pages: 278 - 289
Cancer epidemiology: study designs and data analysis N. MalatsG. Castaño-Vinyals Educational Series 21 June 2007 Pages: 290 - 297
Oxycodone: a pharmacological and clinical review A. Ordóñez GallegoM. González BarónE. Espinosa Arranz Review 21 June 2007 Pages: 298 - 307
Treatment guidelines in ovarian cancer A. Poveda VelascoA. Casado HerráezB. Ojeda González Special Article 21 June 2007 Pages: 308 - 316
Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study L. G. EstévezP. Sánchez-RoviraB. San Antonio Research Articles 21 June 2007 Pages: 317 - 322
Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients A. González-MartínE. FernándezA. Moyano Research Articles 21 June 2007 Pages: 323 - 328
Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia D. Dopico VázquezM. I. Gallegos SanchoL. M. Antón Aparicio Case Reports 21 June 2007 Pages: 329 - 331
False-positive β-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease V. M. Díaz Muñoz de la EspadaJ. A. Arranz ArijaR. González Beca Case Reports 21 June 2007 Pages: 332 - 334
Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma C. Bueno MuiñoJ. Puente VázquezE. Díaz-Rubio Case Reports 21 June 2007 Pages: 335 - 338